Eur Neuropsychopharmacol

• 

  Publication Venue For

  • Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]"..  50:133-134. 2021
  • Assessment of outcomes in autism clinical trials over the course of development..  48:40-41. 2021
  • Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions..  48:3-31. 2021
  • EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial..  44:14-22. 2021
  • The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder..  28:1181-1184. 2018
  • Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale..  25:176-184. 2015
  • The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes..  24:1492-1499. 2014
  • Cognition in schizophrenia: summary Nice Consultation Meeting 2012..  23:769-778. 2013
  • Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial..  22:183-199. 2012